Patients who received ADT for two years were less likely to develop metastatic disease, an expert told CURE®.The addition of two years of androgen ...

To enter, e-mail your photos to  with a short caption and your contact details. Images should be sent as JPEG files and, ideally, be at least 2000px. Feel ...

Patients with advanced or metastatic non-small cell lung cancer (NSCLC) who were previously treated demonstrated promising antitumor intracranial (within ...

The PolyPEPI1018 vaccine, when given with the immunotherapy drug, Tecentriq (atezolizumab), induced immune responses against tumors in a small group of ...

As it had been agreed to keep the information sheet to two pages of A4 (or one A3-sized spread), space was at a premium and every word of text was ...

Zanidatamab continued to be efficacious in treating patients with previously treated advanced, unresectable, or metastatic HER2-amplified biliary tract ...

For patients with relapsed or refractory myeloma, Belamaf (belantamab mafodotin) plus bortezomib and dexamethasone — a regimen referred to as BVd — ...

Patients with myelodysplastic syndrome (MDS) tended to have longer intervals of time when they were not reliant on red blood cell infusions when treated ...

When a good friend reached out to tell me of her breast cancer diagnosis, treatment plan and next steps, I felt like I was going to relive my own breast ...

A novel cancer vaccine, SurVaxM, is being studied for the treatment of patients with newly diagnosed glioblastoma. A trial of the drug is currently fully ...

The safety of oral Onureg (azacitidine) following a decreased dosing schedule remained consistent with the previously known safety profile of the drug in ...

Cancer rates in 25 to 49-year-olds increased by 24% between 1995 and 2019, according to our latest analysis. Around 9 in 10 cancer cases still happen in ...